Effect of day 5 or 6 blastocyst embryo transfer on pregnancy outcomes in euthyroid women undergoing IVF: A single centre retrospective cohort
- PMID: 38848251
- PMCID: PMC11622402
- DOI: 10.5935/1518-0557.20240036
Effect of day 5 or 6 blastocyst embryo transfer on pregnancy outcomes in euthyroid women undergoing IVF: A single centre retrospective cohort
Abstract
Objective: This study examined whether blastocysts transferred on day 5 or day 6 of embryo development, as well as positivity for anti-thyroid peroxidase antibodies, affect gestational outcomes in euthyroid women undergoing in vitro fertilisation.
Methods: Of 428 women who underwent in vitro fertilisation assessed in this retrospective cohort study, 212 (49.5%) underwent embryo transfer on day 5 of blastulation and 216 (50.5%) on day 6. Dichotomization based on anti-thyroid peroxidase antibodies status was also performed, with 370 (86.4%) women testing negative and 58 (13.6%) testing positive. Clinical and hormonal data and rates of clinical pregnancy, miscarriage, and live births were compared between the groups.
Results: When evaluating gestational outcomes based on the day of blastulation, a statistically significant difference was observed in clinical pregnancy rates [51.4% (day 5) vs. 40.7% (day 6); p=0.033]. However, there was no significant difference in the relative frequencies of miscarriages (p=1.000), live births (p=1.000), or preterm births (p=1.000). Using Cramer's V test, a weak association was found between the day of blastulation and clinical pregnancy outcomes (V2=10.7%; p=0.027). There were no statistically significant differences between the anti-thyroid peroxidase antibodies-negative and -positive groups in terms of clinical pregnancy rates (p=0.396), miscarriages (p=0.129), and live births (p=0.129).
Conclusions: Higher rates of clinical pregnancy were observed in women who underwent embryo transfers performed on day 5 compared to those on day 6. However, no effect was observed with gestational outcomes. Further, anti-thyroid peroxidase antibody positivity did not have a statistically significant impact on gestational outcomes.
Keywords: blastocyst; embryo transfer; in vitro fertilization; pregnancy outcome; thyroid peroxidase antibodies.
Figures
Similar articles
-
Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.Hum Reprod. 2021 Mar 18;36(4):929-940. doi: 10.1093/humrep/deab014. Hum Reprod. 2021. PMID: 33608730
-
Does recurrent implantation failure exist? Prevalence and outcomes of five consecutive euploid blastocyst transfers in 123 987 patients.Hum Reprod. 2024 May 2;39(5):974-980. doi: 10.1093/humrep/deae040. Hum Reprod. 2024. PMID: 38452358
-
Abnormal cleavage up to Day 3 does not compromise live birth and neonatal outcomes of embryos that have achieved full blastulation: a retrospective cohort study.Hum Reprod. 2024 May 2;39(5):955-962. doi: 10.1093/humrep/deae062. Hum Reprod. 2024. PMID: 38553025 Free PMC article.
-
Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection.Cochrane Database Syst Rev. 2020 Aug 21;8(8):CD003416. doi: 10.1002/14651858.CD003416.pub5. Cochrane Database Syst Rev. 2020. PMID: 32827168 Free PMC article.
-
Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation.Cochrane Database Syst Rev. 2020 Sep 8;9(9):CD005291. doi: 10.1002/14651858.CD005291.pub3. Cochrane Database Syst Rev. 2020. PMID: 32898291 Free PMC article.
References
-
- Capalbo A, Rienzi L, Cimadomo D, Maggiulli R, Elliott T, Wright G, Nagy ZP, Ubaldi FM. Correlation between standard blastocyst morphology, euploidy, and implantation: An observational study involving 956 screened blastocysts in two centres. Hum Reprod. 2014;29:1173–1181. doi: 10.1093/humrep/deu033. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical